相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。N6-methyladenosine (m6A) is an endogenous A3 adenosine receptor ligand
Akiko Ogawa et al.
MOLECULAR CELL (2021)
FTO-mediated cytoplasmic m6Am demethylation adjusts stem-like properties in colorectal cancer cell
Sebastien Relier et al.
NATURE COMMUNICATIONS (2021)
Development of a gas chromatography-mass spectrometry method for breast cancer diagnosis based on nucleoside metabolomes 1-methyl adenosine, 1-methylguanosine and 8-hydroxy-2′-deoxyguanosine
Mohamed M. Omran et al.
BIOMEDICAL CHROMATOGRAPHY (2020)
NMR-based metabolomics analysis identifies discriminatory metabolic disturbances in tissue and biofluid samples for progressive prostate cancer
Hong Zheng et al.
CLINICA CHIMICA ACTA (2020)
Emerging role of clinical mass spectrometry in pathology
Angela W. S. Fung et al.
JOURNAL OF CLINICAL PATHOLOGY (2020)
Adenosine Signaling Is Prognostic for Cancer Outcome and Has Predictive Utility for Immunotherapeutic Response
Ben Sidders et al.
CLINICAL CANCER RESEARCH (2020)
8-Hydroxyguanosine as a possible RNA oxidative modification marker in urine from colorectal cancer patients: Evaluation by ultra performance liquid chromatography-tandem mass spectrometry
Cheng Guo et al.
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES (2020)
RNA modifications and cancer
Phensinee Haruehanroengra et al.
RNA BIOLOGY (2020)
An Emerging Role for isomiRs and the microRNA Epitranscriptome in Neovascularization
Reginald V. C. T. van der Kwast et al.
CELLS (2020)
Targeted metabolomics: Liquid chromatography coupled to mass spectrometry method development and validation for the identification and quantitation of modified nucleosides as putative cancer biomarkers
Adriana Teixeira Godoy et al.
TALANTA (2020)
N6-methyladenosine RNA modification in cancer therapeutic resistance: Current status and perspectives
Zhijie Xu et al.
BIOCHEMICAL PHARMACOLOGY (2020)
Unraveling the RNA modification code with mass spectrometry
Richard Lauman et al.
MOLECULAR OMICS (2020)
Role of RNA modifications in cancer
Isaia Barbieri et al.
NATURE REVIEWS CANCER (2020)
Dysregulations of Functional RNA Modifications in Cancer, Cancer Stemness and Cancer Therapeutics
Mohammad Burhan Uddin et al.
THERANOSTICS (2020)
Importance of a tRNA anticodon loop modification and a conserved, noncanonical anticodon stem pairing in tRNACGGPro for decoding
Ha An Nguyen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2019)
Functions of RNA N6-methyladenosine modification in cancer progression
Bing Chen et al.
MOLECULAR BIOLOGY REPORTS (2019)
The Relevance of Mass Spectrometry Analysis for Personalized Medicine through Its Successful Application in Cancer Omics
Cristina Alexandra Ciocan-Cartita et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
RNA modifications regulating cell fate in cancer
Sylvain Delaunay et al.
NATURE CELL BIOLOGY (2019)
Determination of cytidine modifications in human urine by liquid chromatography - Mass spectrometry analysis
Yu-Fan Zhang et al.
ANALYTICA CHIMICA ACTA (2019)
Determination of RNA Hydroxylmethylation in Mammals by Mass Spectrometry Analysis
Xue-Jiao You et al.
ANALYTICAL CHEMISTRY (2019)
Benefits of stable isotope labeling in RNA analysis
Paria Asadi-Atoi et al.
BIOLOGICAL CHEMISTRY (2019)
N6-Isopentenyladenosine Inhibits Colorectal Cancer and Improves Sensitivity to 5-Fluorouracil Targeting FBXW7 Tumor Suppressor
Donatella Fiore et al.
CANCERS (2019)
Metabolic profiles of serum samples from ground glass opacity represent potential diagnostic biomarkers for lung cancer
Jian-Zhong Li et al.
TRANSLATIONAL LUNG CANCER RESEARCH (2019)
Development and validation of a rapid LC-MS/MS method for determination of methylated nucleosides and nucleobases in urine
Emilia Rackowska et al.
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES (2019)
Detection of ribonucleoside modifications by liquid chromatography coupled with mass spectrometry
Manasses Jora et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENE REGULATORY MECHANISMS (2019)
Metabolite analysis-aided diagnosis of papillary thyroid cancer
Jian Chen et al.
ENDOCRINE-RELATED CANCER (2019)
Adenosine Generated by Regulatory T Cells Induces CD8+ T Cell Exhaustion in Gastric Cancer through A2aR Pathway
Linsen Shi et al.
BIOMED RESEARCH INTERNATIONAL (2019)
Recognition by natural killer cells of N6-isopentenyladenosine-treated human glioma cell lines
Elena Ciaglia et al.
INTERNATIONAL JOURNAL OF CANCER (2018)
A novel malic acid-enhanced method for the analysis of 5-methyl-2 '-deoxycytidine, 5-hydroxymethyl-2 '-deoxycytidine, 5-methylcytidine and 5-hydroxymethylcytidine in human urine using hydrophilic interaction liquid chromatography-tandem mass spectrometry
Cheng Guo et al.
ANALYTICA CHIMICA ACTA (2018)
Identification of ENTPD8 and cytidine in pancreatic cancer by metabolomic and transcriptomic conjoint analysis
Yong An et al.
CANCER SCIENCE (2018)
Regulatory context and validation of assays for clinical mass spectrometry proteomics (cMSP) methods
Christophe Hirtz et al.
CRITICAL REVIEWS IN CLINICAL LABORATORY SCIENCES (2018)
The Role of m6A/m-RNA Methylation in Stress Response Regulation
Mareen Engel et al.
NEURON (2018)
Modified Nucleosides - Molecular Markers Suitable for Small-volume Cancer? PHILIPP
Philipp Opitz et al.
ANTICANCER RESEARCH (2018)
Impact of tRNA Modifications and tRNA-Modifying Enzymes on Proteostasis and Human Disease
Marisa Pereira et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
N6-isopentenyladenosine a new potential anti-angiogenic compound that targets human microvascular endothelial cells in vitro
Sara Castiglioni et al.
NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS (2018)
N6-isopentenyladenosine dual targeting of AMPK and Rab7 prenylation inhibits melanoma growth through the impairment of autophagic flux
Roberta Ranieri et al.
CELL DEATH AND DIFFERENTIATION (2018)
Post-transcriptional gene regulation by mRNA modifications
Boxuan Simen Zhao et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2017)
Next-generation sequencing technologies for detection of modified nucleotides in RNAs
Schraga Schwartz et al.
RNA BIOLOGY (2017)
Tuning the ribosome: The influence of rRNA modification on eukaryotic ribosome biogenesis and function
Katherine E. Sloan et al.
RNA BIOLOGY (2017)
Translating the epitranscriptome
Thomas Philipp Hoernes et al.
WILEY INTERDISCIPLINARY REVIEWS-RNA (2017)
Epitranscriptome sequencing technologies: decoding RNA modifications
Xiaoyu Li et al.
NATURE METHODS (2017)
Integrated genomic analysis of mitochondrial RNA processing in human cancers
Youssef Idaghdour et al.
GENOME MEDICINE (2017)
Liquid Biopsy: Current Status and Future Perspectives
Sonja Mader et al.
ONCOLOGY RESEARCH AND TREATMENT (2017)
Introduction to nuclear magnetic resonance
Vladimir Mlynarik
ANALYTICAL BIOCHEMISTRY (2017)
Dynamic RNA Modifications in Gene Expression Regulation
Ian A. Roundtree et al.
CELL (2017)
Assessment of nucleosides as putative tumor biomarkers in prostate cancer screening by CE-UV
Adriana Zardini Buzatto et al.
ANALYTICAL AND BIOANALYTICAL CHEMISTRY (2017)
Dot Blot Analysis of N6-methyladenosine RNA Modification Levels
Lisha Shen et al.
BIO-PROTOCOL (2017)
Serum and Plasma Metabolomic Biomarkers for Lung Cancer
Nishith Kumar et al.
BIOINFORMATION (2017)
Review of Physicochemical-Based Diagnostic Techniques for Assessing Insulation Condition in Aged Transformers
Janvier Sylvestre N'cho et al.
ENERGIES (2016)
Urinary 8-oxo-7,8-dihydro-2′-deoxyguanosine analysis by an improved ELISA: An inter-laboratory comparison study
Pavel Rossner et al.
FREE RADICAL BIOLOGY AND MEDICINE (2016)
Advantages and Pitfalls of Mass Spectrometry Based Metabolome Profiling in Systems Biology
Ina Aretz et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2016)
Analysis of RNA modifications by liquid chromatography-tandem mass spectrometry
Kathrin Thuering et al.
METHODS (2016)
Statistical-based approach in potential diagnostic application of urinary nucleosides in urogenital tract cancer
Emilia Daghir-Wojtkowiak et al.
BIOMARKERS IN MEDICINE (2015)
Regulation of deoxynucleotide metabolism in cancer: novel mechanisms and therapeutic implications
Rebecca Kohnken et al.
MOLECULAR CANCER (2015)
Liquid chromatography tandem mass spectrometry in the clinical laboratory
Joanne E. Adaway et al.
ANNALS OF CLINICAL BIOCHEMISTRY (2015)
A System of RNA Modifications and Biased Codon Use Controls Cellular Stress Response at the Level of Translation
Peter C. Dedon et al.
CHEMICAL RESEARCH IN TOXICOLOGY (2014)
Urinary cytidine as an adjunct biomarker to improve the diagnostic ratio for gastric cancer in Taiwanese patients
Wan-Yu Lo et al.
CLINICA CHIMICA ACTA (2014)
Antiangiogenic effects of N6-isopentenyladenosine, an endogenous isoprenoid end product, mediated by AMPK activation
Simona Pisanti et al.
FASEB JOURNAL (2014)
Colorectal Cancer Detection Using Targeted Serum Metabolic Profiling
Jiangjiang Zhu et al.
JOURNAL OF PROTEOME RESEARCH (2014)
The identification and characterization of non-coding and coding RNAs and their modified nucleosides by mass spectrometry
Kirk W. Gaston et al.
RNA BIOLOGY (2014)
Liquid chromatography tandem mass spectrometry study of urinary nucleosides as potential cancer markers
Wiktoria Struck et al.
JOURNAL OF CHROMATOGRAPHY A (2013)
N6-isopentenyladenosine, an endogenous isoprenoid end product, directly affects cytotoxic and regulatory functions of human NK cells through FDPS modulation
Elena Ciaglia et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2013)
Identification of Potential Biomarkers for Ovarian Cancer by Urinary Metabolomic Profiling
Tao Zhang et al.
JOURNAL OF PROTEOME RESEARCH (2013)
Urinary Nucleosides as Biomarkers of Breast, Colon, Lung, and Gastric Cancer in Taiwanese
Wei-Yi Hsu et al.
PLOS ONE (2013)
Identification of serum biomarkers of hepatocarcinoma through liquid chromatography/mass spectrometry-based metabonomic method
Feng Chen et al.
ANALYTICAL AND BIOANALYTICAL CHEMISTRY (2011)
Antiproliferative Activity of N6-Isopentenyladenosine on HCT-15 Colon Carcinoma Cell Line
Mehdi Rajabi et al.
NUCLEIC ACID THERAPEUTICS (2011)
Altered levels of nucleoside metabolite profiles in urogenital tract cancer measured by capillary electrophoresis
Ewa Szymanska et al.
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS (2010)
Targeted serum metabolite profiling of nucleosides in esophageal adenocarcinoma
Danijel Djukovic et al.
RAPID COMMUNICATIONS IN MASS SPECTROMETRY (2010)
A Fast Capillary Electrophoresis Method for Separation and Quantification of Modified Nucleosides in Urinary Samples
Yongqing Jiang et al.
ANALYTICAL CHEMISTRY (2009)
Mass spectrometry based metabolomic approaches in urinary biomarker study of women's cancers
Han Min Woo et al.
CLINICA CHIMICA ACTA (2009)
Evaluation of urinary nucleosides in breast cancer patients before and after tumor removal
Sung-Hee Cho et al.
CLINICAL BIOCHEMISTRY (2009)
N6-isopentenyladenosine inhibits cell proliferation and induces apoptosis in a human colon cancer cell line DLD1
Chiara Laezza et al.
INTERNATIONAL JOURNAL OF CANCER (2009)
Loss of rRNA modifications in the decoding center of the ribosome impairs translation and strongly delays pre-rRNA processing
Xue-Hai Liang et al.
RNA (2009)
Multilayer perceptron tumour diagnosis based on chromatography analysis of urinary nucleosides
P. Seidel et al.
NEURAL NETWORKS (2007)
N6-isopentenyladenosine: A potential therapeutic agent for a variety of epithelial cancers
Monica Spinola et al.
INTERNATIONAL JOURNAL OF CANCER (2007)
Future of liquid chromatography-mass spectrometry in metabolic profiling and metabolomic studies for biomarker discovery
Thomas O. Metz et al.
BIOMARKERS IN MEDICINE (2007)
Genetic and epigenetic alterations as biomarkers for cancer detection, diagnosis and prognosis
Zdenko Herceg et al.
MOLECULAR ONCOLOGY (2007)
Pseudouridine synthases
Tomoko Hammal et al.
CHEMISTRY & BIOLOGY (2006)
Normal and modified urinary nucleosides represent novel biomarkers for colorectal cancer diagnosis and surgery monitoring
B Feng et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2005)
The expanding role of mass spectrometry in metabolite profiling and characterization
EJ Want et al.
CHEMBIOCHEM (2005)
分享论文
